SIA
MEDP icon

Soltis Investment Advisors’s Medpace MEDP Stock Holding History

Soltis Investment Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
416
-22
-5% -$10.2K 0.01% 595
2026
Q1 		$210K Buy
438
+53
+14% +$27.1K 0.01% 538
2025
Q4 		$216K Buy
+385
New +$219K 0.01% 490

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Soltis Investment Advisors's MEDP Position: Q2 2026 in Review

Soltis Investment Advisors reduced its Medpace (MEDP) stake by 5% in Q2 2026, selling an estimated $10.2K and leaving 416 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #595.

Soltis Investment Advisors first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Soltis Investment Advisors held 416 shares of Medpace worth $220K as of Q2 2026.
  • Soltis Investment Advisors sold 22 Medpace shares in Q2 2026, an estimated $10.2K.
  • Medpace made up 0.01% of Soltis Investment Advisors's portfolio in Q2 2026, its #595 holding.
  • Soltis Investment Advisors first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.